{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:16Z","timestamp":1793946376031,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130926","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:10:21Z","timestamp":1772730621000},"page":"130926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interleukin-27 promotes oral squamous cell carcinoma pathogenesis via FSIP1-mediated activation of the PI3K-Akt signaling pathway"],"prefix":"10.1016","volume":"1870","author":[{"given":"Qing-Mei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130926_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122864","article-title":"Noninvasive imaging methods to improve the diagnosis of Oral carcinoma and its precursors: state of the art and proposal of a three-step diagnostic process","volume":"13","author":"Romano","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130926_bb0015","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jcms.2017.08.020","article-title":"Clinicopathological parameters affecting nodal yields in patients with oral squamous cell carcinoma receiving selective neck dissection","volume":"45","author":"Safi","year":"2017","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.bbagen.2026.130926_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oraloncology.2018.04.011","article-title":"Age- and localization-dependent functional and psychosocial impairments and health related quality of life six months after OSCC therapy","volume":"81","author":"Linsen","year":"2018","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12903-019-0760-2","article-title":"Health-related quality of life: a retrospective study on local vs. microvascular reconstruction in patients with oral cancer","volume":"19","author":"Meier","year":"2019","journal-title":"BMC Oral Health"},{"issue":"8","key":"10.1016\/j.bbagen.2026.130926_bb0030","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating Centre for Oral Cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130926_bb0035","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/odi.13810","article-title":"Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years","volume":"27","author":"Aguirre-Urizar","year":"2021","journal-title":"Oral Dis."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130926_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tripleo.2011.04.009","article-title":"Oral lichen planus and malignant transformation: a longitudinal cohort study","volume":"112","author":"Bombeccari","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130926_bb0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13402-025-01068-3","article-title":"Trends in immunotherapy for oral squamous cell carcinoma","volume":"48","author":"Xue","year":"2025","journal-title":"Cell. Oncol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130926_bb0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2018.01.004","article-title":"Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature","volume":"44","author":"Brands","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130926_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130926_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/imt.14.95","article-title":"The yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy","volume":"7","author":"Li","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbagen.2026.130926_bb0065","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/OTT.S173207","article-title":"IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro","volume":"12","author":"Wang","year":"2019","journal-title":"Onco. Targets Ther."},{"issue":"21","key":"10.1016\/j.bbagen.2026.130926_bb0070","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.18632\/oncotarget.1425","article-title":"The antitumor potential of Interleukin-27 in prostate cancer","volume":"5","author":"Di Carlo","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130926_bb0075","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.18632\/oncotarget.2797","article-title":"Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer","volume":"6","author":"Airoldi","year":"2015","journal-title":"Oncotarget"},{"issue":"8055","key":"10.1016\/j.bbagen.2026.130926_bb0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41586-024-08510-w","article-title":"IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control","volume":"639","author":"Br\u00e9art","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130926_bb0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/jir.2015.0091","article-title":"IL-27 promotes proliferation of human leukemic cell lines through the MAPK\/ERK signaling pathway and suppresses sensitivity to chemotherapeutic drugs","volume":"36","author":"Jia","year":"2016","journal-title":"J. Interf. Cytokine Res."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130926_bb0090","first-page":"683","article-title":"Concentration of serum interleukin-27 increase in patients with lymph node metastatic gastroesophageal cancer","volume":"22","author":"Diakowska","year":"2013","journal-title":"Adv. Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130926_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075694","article-title":"Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]","volume":"8","author":"Gonin","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbagen.2026.130926_bb0100","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.1810254116","article-title":"IL-27 confers a protumorigenic activity of regulatory T cells via CD39","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130926_bb0105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10753-021-01599-5","article-title":"Expressions of Interleukin-27 in Oral lichen planus, oral leukoplakia, and oral squamous cell carcinoma","volume":"45","author":"Wang","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.bbagen.2026.130926_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101969","article-title":"Bi-allelic mutation in Fsip1 impairs acrosome vesicle formation and attenuates flagellogenesis in mice","volume":"43","author":"Gamallat","year":"2021","journal-title":"Redox Biol."},{"issue":"51","key":"10.1016\/j.bbagen.2026.130926_bb0115","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1809681115","article-title":"FSIP1 regulates autophagy in breast cancer","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbagen.2026.130926_bb0120","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/OTT.S158275","article-title":"Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K\/AKT pathway","volume":"11","author":"Sun","year":"2018","journal-title":"Onco. Targets Ther."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130926_bb0125","doi-asserted-by":"crossref","first-page":"12186","DOI":"10.18632\/oncotarget.14575","article-title":"Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients","volume":"8","author":"Mao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2026.130926_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2478551","article-title":"FSIP1 is associated with poor prognosis and can be used to construct a prognostic model in gastric cancer","volume":"2022","author":"Yan","year":"2022","journal-title":"Dis. Markers"},{"issue":"16","key":"10.1016\/j.bbagen.2026.130926_bb0135","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1158\/1078-0432.CCR-10-0173","article-title":"Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma","volume":"16","author":"Cocco","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130926_bb0140","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130926_bb0145","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/curroncol30040283","article-title":"Oral squamous cell carcinoma and concomitant primary tumors, what do we know? A review of the literature","volume":"30","author":"Badwelan","year":"2023","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12903-022-02398-6","article-title":"A survey of the awareness and knowledge of oral cancer among residents in Beijing","volume":"22","author":"Zhou","year":"2022","journal-title":"BMC Oral Health"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130926_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18094506","article-title":"Current knowledge, attitudes, and practice among health care providers in OSCC awareness: systematic review and meta-analysis","volume":"18","author":"Coppola","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbagen.2026.130926_bb0160","first-page":"1053","article-title":"Clinicopathological characteristics of oral squamous cell carcinoma at the central referral and teaching hospital in west java, Indonesia","volume":"16","author":"Sufiawati","year":"2024","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbagen.2026.130926_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70000","article-title":"Epigenetic remodeling under oxidative stress: mechanisms driving tumor metastasis","volume":"3","author":"Peng","year":"2024","journal-title":"MedComm-Oncology"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/1756-9966-32-97","article-title":"IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer","volume":"32","author":"Kachroo","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.bbagen.2026.130926_bb0175","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1158\/0008-5472.CAN-16-0189","article-title":"Interleukin-30 promotes breast cancer growth and progression","volume":"76","author":"Airoldi","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130926_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.69","article-title":"Insight into Janus kinases specificity: from molecular architecture to cancer therapeutics","volume":"3","author":"Wei","year":"2024","journal-title":"MedComm-Oncology"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130926_bb0185","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s11427-023-2343-y","article-title":"FSIP1 enhances the therapeutic sensitivity to CDK4\/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway","volume":"66","author":"Chen","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0190","doi-asserted-by":"crossref","first-page":"20240964","DOI":"10.1515\/med-2024-0964","article-title":"Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment","volume":"19","author":"Liu","year":"2024","journal-title":"Open Med. (Wars)"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130926_bb0195","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/1541-7786.MCR-20-0818","article-title":"Phosphorylation and driver mutations in PI3K\u03b1 and PTEN autoinhibition","volume":"19","author":"Nussinov","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130926_bb0200","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biopha.2018.10.182","article-title":"Piperlongumine, a piper alkaloid targets Ras\/PI3K\/Akt\/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH\/DSS induced experimental colon cancer","volume":"109","author":"Kumar","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130926_bb0205","first-page":"588","article-title":"Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K\/AKT and MAPK\/ERK signaling pathways in gastric cancer","volume":"23","author":"Li","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130926_bb0210","doi-asserted-by":"crossref","first-page":"20471","DOI":"10.1038\/s41598-024-71602-0","article-title":"KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K\/AKT signaling pathway","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2026.130926_bb0215","article-title":"P38 mitogen-activated protein kinase: functions and targeted therapy in diseases","volume":"2","author":"Zheng","year":"2023","journal-title":"MedComm \u2013 Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:31:20Z","timestamp":1793943080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000267"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130926","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-27 promotes oral squamous cell carcinoma pathogenesis via FSIP1-mediated activation of the PI3K-Akt signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130926"}}